Nitto Avecia
Nitto Avecia Pharma Services is a cGMP-compliant CDMO providing analytical testing and oligonucleotide manufacturing services to pharmaceutical, biotech, and medical device companies from FDA-inspected facilities in Irvine, California.
- Company typePrivate
- Founded1988
- HeadquartersIrvine, United States
- Headcount101–250
- GTM type—
- Offering—
What Nitto Avecia does
Nitto Avecia (operated through Nitto Avecia Pharma Services, Inc., a Delaware corporation headquartered at 10 Vanderbilt Avenue, Irvine, California) is a cGMP-compliant analytical testing and contract manufacturing organization focused on pharmaceutical, biotechnology, and medical device clients. The company operates from two adjacent buildings in Irvine covering 30,000 square feet of laboratory space and has been performing USP compendial methods since its inception in 1988, accumulating more than 30 years of operating history and thousands of validated analytical methods.
Its service portfolio spans Quality Control and Stability, Analytical Development and Validation, Compendial Testing (USP/EP/BP/JP), Elemental Impurity Analysis, Extractables and Leachables, Microbiological Testing, Protein and Gene Therapy Analysis (CAR-T, AAV, mAb, CRISPR), Bioassays/ELISA, and FTE staffing. The company is integrated with its sister entity Nitto Avecia (Nitto Denko Avecia), one of the world's larger oligonucleotide drug substance manufacturers with 25+ years of experience producing more than 1,200 oligonucleotide sequences, allowing end-to-end preclinical-to-commercial support for oligonucleotide programs.
Nitto Avecia generates revenue through project-based contracts, Full-Time Equivalent staffing, and Master Service Agreements sold via a direct enterprise sales motion and relationship-led business development. Customers include pharmaceutical and biotech sponsors (Phio Pharmaceuticals is publicly cited for commercial-scale PH-762 production), and the company maintains FDA-inspected, ICH-aligned cGMP compliance, completing a 2025 FDA inspection with zero Form 483 observations.
Nitto Avecia firmographics
Firmographics- Name
- Nitto Avecia
- Legal name
- Nitto Avecia Pharma Services, Inc.
- Website
- https://aveciapharma.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Nitto Avecia Pharma Services is a cGMP-compliant CDMO providing analytical testing and oligonucleotide manufacturing services to pharmaceutical, biotech, and medical device companies from FDA-inspected facilities in Irvine, California.
- Ownership category
- akta.pro rank
Nitto Avecia industry classification
Industry- Product category
- Pharmaceutical Contract Analytical and Manufacturing Services (CDMO)
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industries
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where Nitto Avecia is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Nitto Avecia business model
Business model- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Analytical Testing Services: Provides comprehensive analytical chemistry testing services for pharmaceutical and biotech companies including method development, validation, quality control, stability studies, compendial testing, elemental impurity analysis, extractables/leachables testing, and microbiological testing. Revenue is generated through project-based contracts with pharmaceutical clients.
- Oligonucleotide Manufacturing Services: Drug substance oligonucleotide manufacturing services from preclinical through commercial scale through partnership with Nitto Avecia. Services include analytical method development and validation, stability studies, and product characterization.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Nitto Avecia product offering
Product offeringCore offering
Nitto Avecia Pharma Services is a contract development and manufacturing organization (CDMO) providing analytical testing services to pharmaceutical, biotechnology, and medical device companies. Operating from FDA-inspected, cGMP-compliant facilities in Irvine, California, the company delivers a comprehensive suite of analytical services—including quality control, stability studies, analytical development, compendial testing, elemental impurities, extractables/leachables, microbiological testing, gene therapy analysis, and bioassays—integrated with parent Nitto Avecia's oligonucleotide drug substance manufacturing capabilities to provide end-to-end support from preclinical through commercial scale.
Product overview
Nitto Avecia Pharma Services is a single-source analytical testing and manufacturing services provider for pharmaceutical, biotech, and medical device industries. The company operates as a unified platform combining analytical services with GMP drug substance manufacturing through its partnership with Nitto Avecia. The service portfolio includes Quality Control & Stability Studies, Analytical Development, Oligonucleotide Services, Compendial Testing, Elemental Impurity Analysis, Extractables & Leachables Testing, Microbiological Testing, Protein & Gene Therapy Analysis, Bioassays and ELISA, and FTE Services. Together with Nitto Avecia's manufacturing capabilities, the company offers end-to-end support from preclinical development through commercial production.
Differentiator
Problem solved
Functional benefit
Products and services
- Analytical Services Comprehensive analytical testing services for pharmaceutical, biotech, and medical device companies covering the drug development lifecycle from analytical chemistry through quality control and stability studies.
- Quality Control & Stability Studies cGMP-validated photostability equipment and environmental chambers for protecting product quality, integrity, and security; includes stability study design, freeze/thaw studies, and stability indicating method development.
- Analytical Development & Validation Method development and validation services for pharmaceutical drug substances and drug products, supporting regulatory applications with gap analysis, remedial validation, and technology transfer.
- Oligonucleotide Services Integrated oligonucleotide solutions including analytical method development, validation, stability studies, and drug substance manufacturing from preclinical to commercial scale through the Nitto Avecia partnership.
- Compendial Testing USP, EP, BP, JP, and customer-specified monograph testing for drug substances, drug products, and various dosage forms including tablets, capsules, parenterals, and transdermal products.
- Elemental Impurity Analysis Elemental impurity testing compliant with USP <232>, <233> and ICH guidelines using ICP-MS, ICP-OES, Graphite AA, Flame AA, and Cold Vapor AA instrumentation.
- Extractables & Leachables Testing Container/closure system safety evaluation using a three-phase systematic approach including control extraction studies, model extraction studies, and leachable studies.
- Microbiological Testing cGMP microbiological testing including compendial methods, microbial limits, endotoxin testing (Gel-clot, Kinetic Chromogenic, Kinetic Turbidimetric), sterility testing, and environmental monitoring.
- Protein & Gene Therapy Analysis Gene therapy testing services for CAR-T, AAV, mAb, protein and CRISPR products including release testing, virus capsid testing, protein expression, genomic analysis, and guide RNA synthesis.
- Bioassays and ELISA Bioassay and cell-based assay services including Master and Working Cell Bank generation, cell culture, ELISA analyses, flow cytometry assays, kinase/phosphatase assays, and bioassay release testing.
- Full-Time Equivalent (FTE) Services Dedicated scientist staffing for client projects with FTE project staffing and hybrid resource models, providing analytical development, formulation development, and QC testing expertise.
Quantifiable outcome
- Successfully completed 2025 FDA inspection with zero Form 483 observations
- +2 more outcomes
Companies that use Nitto Avecia
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Nitto Avecia technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Nitto Avecia partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Phio PharmaceuticalscoreDrug substance services agreement for commercial-scale cGMP production of PH-762, Phio's lead drug candidate for intratumoral cancer treatment. Avecia conducted analytical development, method validation, and manufacturing services to support upcoming clinical trials following Phase 1b dose-escalation study completion.
- Nitto Denko CorporationcoreNitto Avecia and Nitto Avecia Pharma Services operate as part of Nitto Group, sharing common vision of 'Creating Wonders.' Nitto Denko Avecia is the world's premier oligonucleotide manufacturer, working seamlessly with Nitto Avecia Pharma Services to provide integrated support.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Nitto Avecia competitors and assessment
Company assessmentBroad incumbents
- Catalent: Catalent is a large global CDMO offering drug substance and drug product development across multiple modalities including oligonucleotides and biologics. It competes with Nitto Avecia for outsourced pharmaceutical manufacturing and analytical work, but operates at significantly broader scale across many sites and dosage forms.
- Thermo Fisher Scientific (Patheon): Thermo Fisher's Patheon CDMO business provides integrated drug development, manufacturing, and analytical services to pharma and biotech globally. It is comparable as a large, multi-site CDMO offering analytical testing alongside drug substance and drug product services similar to Nitto Avecia's combined model.
- Lonza: Lonza is a leading global CDMO with extensive small-molecule, biologic, and oligonucleotide manufacturing capabilities. It competes with Nitto Avecia in oligo CDMO and analytical services while offering far greater geographic reach and capacity.
- WuXi STA: WuXi STA is the small-molecule CDMO arm of WuXi AppTec, offering end-to-end development, manufacturing, and analytical services. It competes with Nitto Avecia for pharma outsourcing contracts, particularly in analytical and oligonucleotide-related work.
- Eurofins Scientific: Eurofins is a large contract testing organization providing analytical, microbiological, and pharmaceutical quality testing services. It overlaps directly with Nitto Avecia Pharma Services' analytical testing offering for pharma and biotech clients.
- Charles River Laboratories: Charles River provides discovery, safety assessment, and manufacturing services to the pharma and biotech industries, including biologics and cell/gene therapy testing. It is comparable as a CRO/CDMO with strong analytical and QC capabilities serving similar pharma customers.
Direct peers
- Curia (formerly AMRI): Curia is a CDMO offering small-molecule API manufacturing, analytical services, and drug product development for pharmaceutical companies. It directly competes with Nitto Avecia in contract analytical testing and CDMO services for small-molecule and complex therapeutics.
- Ajinomoto Bio-Pharma Services: Ajinomoto Bio-Pharma is a CDMO specializing in small-molecule API, oligonucleotide, and peptide manufacturing with integrated analytical services. It is a direct comparable to Nitto Avecia in oligo-focused CDMO and analytical offerings.
- Asymchem: Asymchem is a China-based CDMO offering small-molecule API development and manufacturing, including oligonucleotide and peptide capabilities. It competes with Nitto Avecia for outsourced pharma manufacturing programs targeting global pharma customers.
Regional players
- Element Materials Testing: Element is a global testing, inspection, and certification company with pharma and life-sciences analytical services. It is comparable as a contract testing organization serving pharma and biotech, though it does not provide oligonucleotide manufacturing like Nitto Avecia.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Nitto Avecia social profiles
Digital presenceNitto Avecia compliance and trust
Trust signalCompliance4 records
Nitto Avecia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nitto Avecia leadership team
Management profileNumber of profiles
Profiles18 records
Nitto Avecia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nitto Avecia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nitto Avecia
What does Nitto Avecia do?
Nitto Avecia Pharma Services is a contract development and manufacturing organization (CDMO) providing analytical testing services to pharmaceutical, biotechnology, and medical device companies. Operating from FDA-inspected, cGMP-compliant facilities in Irvine, California, the company delivers a comprehensive suite of analytical services—including quality control, stability studies, analytical development, compendial testing, elemental impurities, extractables/leachables, microbiological testing, gene therapy analysis, and bioassays—integrated with parent Nitto Avecia's oligonucleotide drug substance manufacturing capabilities to provide end-to-end support from preclinical through commercial scale.
Is Nitto Avecia a public or private company?
Nitto Avecia is a private company. It is classified as corporate owned and is currently operating.
When was Nitto Avecia founded?
Nitto Avecia was founded in 1988. It employs 101 to 250 people.
Where is Nitto Avecia based?
Nitto Avecia is headquartered in Irvine, United States, in the North America region.
How does Nitto Avecia make money?
Two revenue lines are on record. Analytical Testing Services are the primary driver. The others are oligonucleotide Manufacturing Services.
Who are Nitto Avecia's main competitors?
Broad incumbents on record are Catalent, Thermo Fisher Scientific (Patheon), Lonza, WuXi STA, Eurofins Scientific and Charles River Laboratories. Direct peers are Curia (formerly AMRI), Ajinomoto Bio-Pharma Services and Asymchem. Element Materials Testing is listed as a regional player.
Does Nitto Avecia have an API?
No public API is recorded for Nitto Avecia.
What industry is Nitto Avecia in?
Nitto Avecia's product category is Pharmaceutical Contract Analytical and Manufacturing Services (CDMO). Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 32541 and its SIC code is 8731.